OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 19 citing articles:

Alpha-1 Acid Glycoprotein Reduction Differentiated Recovery from Remission in a Small Cohort of Cats Treated for Feline Infectious Peritonitis
Diane Addie, Carla Silveira, Charlotte Aston, et al.
Viruses (2022) Vol. 14, Iss. 4, pp. 744-744
Open Access | Times Cited: 16

Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Drug Targets (2022) Vol. 23, Iss. 13, pp. 1277-1287
Closed Access | Times Cited: 10

Treating COVID-19: Targeting the Host Response, Not the Virus
David S. Fedson
Life (2023) Vol. 13, Iss. 3, pp. 712-712
Open Access | Times Cited: 4

Binding behavior of receptor binding domain of the SARS-CoV-2 virus and ivermectin
Kasidy R. Gossen, Meiyi Zhang, Z̆ivko L. Nikolov, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1

Trust Us—We Are the (COVID-19 Misinformation) Experts: A Critical Scoping Review of Expert Meanings of “Misinformation” in the Covid Era
Claudia Chaufan, Natalie Hemsing, Camila Heredia, et al.
COVID (2024) Vol. 4, Iss. 9, pp. 1413-1439
Open Access | Times Cited: 1

Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19
Hoda Awad, Basmala Hassan, Sara Dweek, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 9, pp. 1068-1068
Open Access | Times Cited: 6

Results of a systematic review and meta-analysis of early studies on ivermectin in SARS-CoV-2 infection
Zsuzsanna Ragó, Barbara Tóth, Ágnes Szalenkó-Tőkés, et al.
GeroScience (2023) Vol. 45, Iss. 4, pp. 2179-2193
Open Access | Times Cited: 3

Ivermectin modulated cerebral γ-aminobutyric acid (GABA) and reduced the number of chronic Toxoplasma gondii cysts significantly in the brains of immunocompromised mice
Mennat-Elrahman Ahmed Fahmy, Maisa Ahmed Shalaby, Ragaa Issa, et al.
Journal of Parasitic Diseases (2023) Vol. 47, Iss. 3, pp. 635-643
Open Access | Times Cited: 2

Covid-19 pandemic and scientific knowledge: logical implications for dealing with truth
Marcelo Simões Mendes
Ethics Medicine and Public Health (2023) Vol. 31, pp. 100947-100947
Closed Access | Times Cited: 1

Appraising the decision-making process concerning COVID-19 policy in postsecondary education in Canada: A critical scoping review protocol
Claudia Chaufan, Laurie A. Manwell, Benjamin Gabbay, et al.
AIMS Public Health (2023) Vol. 10, Iss. 4, pp. 918-933
Open Access | Times Cited: 1

Pandemic, science and health: between determinisms and determinations
Marcelo Simões Mendes
Journal of Public Health (2024)
Closed Access

The Place of Ivermectin in the Management of Covid-19: State of the Evidence
Babalola O.E, Ajayi A.A
Medical Research Archives (2023) Vol. 11, Iss. 4
Open Access

Ivermectin as a Repurposed Drug for COVID‐19
Hari Madhav, Mohammad Rehan, Nasimul Hoda, et al.
(2023), pp. 47-68
Closed Access

Page 1

Scroll to top